Semtech
SMTC Nasdaq Semiconductors Financials FY2017βFY2026
Semtech's revenue rose 15.5% to $1.1 billion in fiscal 2026. Its operating margin was 3.1%, down from 5.5% a year earlier. Free cash flow was $171 million, up 241.9%. The diluted share count rose 23.4%.
What Semtech does
No business description yet.
- Legal name
- Semtech Corporation
- Fiscal year ends
- January 25, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0000088941-26-000005
0000088941
Revenue and margins
Semtech had $1.1B of revenue in fiscal 2026, up 15.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $171M in fiscal 2026, 16.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Semtech returned $0.0M to shareholders in fiscal 2026, 0% of free cash flow. The diluted share count rose 23.4%.
Value Semtech yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$296M and divides by 88.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Semtech can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $292M | $248M | $143M | $165M | $195M |
| Debt incl. finance leases | $172M | $1.3B | $1.4B | $552M | $491M |
| Net debt / EBITDA | β0.7x | 9.1x | β | 4.6x | 4.7x |
| Debt / equity | 0.2x | 1.8x | β | 1.0x | 0.9x |
| Interest coverage | 28.5x | 5.3x | β9.9x | 0.6x | 0.8x |
| Current ratio | 3.9x | 1.8x | 2.5x | 2.1x | 2.4x |
| Quick ratio | 3.0x | 1.3x | 1.8x | 1.5x | 1.7x |
| Total assets | $1.1B | $2.6B | $1.4B | $1.4B | $1.4B |
| Total liabilities | $393M | $1.8B | $1.7B | $877M | $861M |
| Shareholders' equity | $738M | $756M | β$307M | $542M | $550M |
| Net debt (β = net cash) | β$120M | $1.1B | $1.2B | $387M | $296M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.5M
6 insiders
Of sales under plans
81%
$3.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Paul Walsh V JrDirector | Sold plan | 500 | $172.61 | $0.1M | Form 4 |
| Sep 16, 2026 | Rodolpho C CardenutoDirector | Sold | 5,321 | $165.00 | $0.9M | Form 4 |
| Sep 10, 2026 | Mark LinEVP and CFO | Sold plan | 683 | $159.90 | $0.1M | Form 4 |
| Sep 4, 2026 | Hong Q HouPresident and CEO, Director | Sold plan | 2,000 | $138.71 | $0.3M | Form 4 |
| Sep 4, 2026 | Julie Garcia RuehlDirector | Sold plan | 1,500 | $145.00 | $0.2M | Form 4 |
| Aug 19, 2026 | Paul Walsh V JrDirector | Sold plan | 500 | $135.48 | $0.1M | Form 4 |
| Aug 17, 2026 | Asaf SilbersteinEVP and COO | Sold plan | 5,000 | $150.00 | $0.8M | Form 4 |
| Aug 7, 2026 | Hong Q HouPresident and CEO, Director | Sold plan | 2,000 | $140.00 | $0.3M | Form 4 |
| Jul 22, 2026 | Paul Walsh V JrDirector | Sold plan | 500 | $133.07 | $0.1M | Form 4 |
| Jul 14, 2026 | Asaf SilbersteinEVP and COO | Sold plan | 3,000 | $145.04 | $0.4M | Form 4 |
| Jul 10, 2026 | Hong Q HouPresident and CEO, Director | Sold plan | 2,000 | $133.00 | $0.3M | Form 4 |
| Jul 8, 2026 | Asaf SilbersteinEVP and COO | Sold plan | 8,500 | $127.80 | $1.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 3 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β50.6% | β15.8% | β15.7% |
| Altman Z'' | β3.85 | 1.37 | 1.58 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Semtech SMTC | $12.9B | 15.5% | 3.1% | 16.3% | 2.9% | β | 7 | |
| MACOM Technology Solutions MTSI | $18.5B | 32.6% | 13.4% | 19.9% | 9.8% | 75.2x | 5 | Compare β |
| Synaptics SYNA | $4.6B | 11.4% | β5.6% | 8.5% | β3.4% | β | 5 | Compare β |
| Allegro MicroSystems ALGM | $5.9B | 22.8% | 2.1% | 14.0% | 1.3% | β | 7 | Compare β |
| Silicon Labs SLAB | $7.3B | 34.3% | β9.0% | 8.4% | β7.0% | β | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $544M | $588M | $627M | $548M | $595M | $741M | $757M | $869M | $909M | $1.1B |
| Gross profit | $325M | $352M | $377M | $337M | $356M | $461M | $479M | $296M | $457M | $542M |
| Research and development | $103M | $105M | $109M | $107M | $118M | $148M | $167M | $186M | $171M | $196M |
| Operating income | $84.1M | $66.6M | $106M | $52.0M | $75.0M | $145M | $92.8M | β$944M | $49.9M | $32.6M |
| Interest expense | $6.5M | $7.4M | $8.7M | $8.6M | $5.3M | $5.1M | $17.6M | $95.8M | $90.1M | $40.6M |
| Pretax income | $73.1M | $57.8M | $70.1M | $44.6M | $63.0M | $139M | $78.5M | β$1.0B | β$183M | β$21.2M |
| Income tax | $18.4M | $22.9M | $0.4M | $12.8M | $3.4M | $15.5M | $17.3M | $50.5M | β$22.0M | $19.8M |
| Net income | $54.7M | $34.6M | $69.6M | $31.9M | $59.9M | $126M | $61.4M | β$1.1B | β$162M | β$40.4M |
| Diluted EPS | $0.83 | $0.51 | $1.02 | $0.47 | $0.91 | $1.92 | $0.96 | β$17.03 | β$2.26 | β$0.46 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.07B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | $118M | $112M | $184M | $119M | $119M | $203M | $127M | β$93.9M | $58.0M | $181M |
| Capital expenditure | $32.9M | $35.5M | $17.1M | $23.1M | $32.7M | $26.2M | $28.3M | $29.2M | $7.9M | $9.8M |
| Free cash flow | $84.7M | $76.0M | $167M | $95.6M | $86.2M | $177M | $98.4M | β$123M | $50.1M | $171M |
| Depreciation and amortization | $47.1M | $49.0M | $49.6M | $39.6M | $24.2M | $26.0M | $26.6M | $44.2M | $34.1M | $30.5M |
| Stock-based compensation | $30.8M | $50.1M | $66.8M | $52.0M | $53.0M | $51.2M | $39.2M | $40.2M | $68.0M | $57.7M |
| Acquisitions | $0.0M | $17.6M | $15.9M | $0.0M | $0.0M | $0.0M | $1.2B | $0.0M | $0.0M | $21.5M |
| Share buybacks | $1.0M | $14.8M | $116M | $70.2M | $71.4M | $130M | $50.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $1.0M | $14.9M | $116M | $70.2M | $71.4M | $130M | $50.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $297M | $308M | $312M | $293M | $269M | $292M | $248M | $143M | $165M | $195M |
| Total debt | $241M | $227M | $211M | $195M | $179M | $172M | $1.3B | $1.4B | $552M | $491M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $438M | $461M | $485M | $461M | $475M | $502M | $723M | $534M | $586M | $655M |
| Current liabilities | $123M | $126M | $130M | $98.6M | $110M | $128M | $397M | $217M | $283M | $276M |
| Inventory | $65.9M | $71.1M | $63.7M | $73.0M | $87.5M | $114M | $208M | $145M | $164M | $196M |
| Property and equipment, net | $109M | $125M | $119M | $124M | $131M | $135M | $169M | $154M | $126M | $109M |
| Total assets | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $2.6B | $1.4B | $1.4B | $1.4B |
| Total liabilities | $406M | $421M | $380M | $375M | $383M | $393M | $1.8B | $1.7B | $877M | $861M |
| Shareholders' equity | $605M | $665M | $683M | $677M | $699M | $738M | $756M | β$307M | $542M | $550M |
| Margins | ||||||||||
| Gross margin | 59.7% | 59.9% | 60.1% | 61.5% | 59.8% | 62.2% | 63.3% | 34.1% | 50.2% | 51.6% |
| Operating margin | 15.5% | 11.3% | 16.8% | 9.5% | 12.6% | 19.6% | 12.3% | β108.7% | 5.5% | 3.1% |
| EBITDA margin | 24.1% | 19.7% | 24.7% | 16.7% | 16.7% | 23.1% | 15.8% | β103.6% | 9.2% | 6.0% |
| Net margin | 10.0% | 5.9% | 11.1% | 5.8% | 10.1% | 17.0% | 8.1% | β125.7% | β17.8% | β3.9% |
| FCF margin | 15.6% | 12.9% | 26.6% | 17.5% | 14.5% | 23.9% | 13.0% | β14.2% | 5.5% | 16.3% |
| Returns | ||||||||||
| Return on capital | 11.2% | 7.1% | 18.0% | 6.4% | 11.9% | 21.0% | 5.9% | β53.9% | 4.3% | 2.9% |
| Return on capital employed | 9.9% | 7.2% | 11.2% | 5.5% | 7.8% | 14.7% | 5.9% | β56.7% | 4.4% | 2.9% |
| Return on equity | 9.7% | 5.5% | 10.3% | 4.7% | 8.7% | 17.5% | 8.2% | β487.1% | β137.8% | β7.4% |
| Return on assets | 5.7% | 3.3% | 6.5% | 3.0% | 5.6% | 11.4% | 3.3% | β55.4% | β11.6% | β2.9% |
| Growth | ||||||||||
| Revenue growth | 11.0% | 8.0% | 6.7% | β12.7% | 8.7% | 24.5% | 2.1% | 14.8% | 4.7% | 15.5% |
| Net income growth | 375.4% | β36.6% | 101.0% | β54.2% | 88.0% | 109.8% | β51.2% | β1,879.1% | β | β |
| EPS growth | 388.2% | β38.6% | 100.0% | β53.9% | 93.6% | 111.0% | β50.0% | β1,874.0% | β | β |
| FCF growth | β4.9% | β10.2% | 119.0% | β42.6% | β9.8% | 105.3% | β44.4% | β225.1% | β | 241.9% |
| Share count change | 0.2% | 2.3% | 1.3% | β1.6% | β2.0% | β0.8% | β2.4% | 0.2% | 11.7% | 23.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.4x | β0.7x | β0.7x | β1.1x | β0.9x | β0.7x | 9.1x | β | 4.6x | 4.7x |
| Debt / equity | 0.4x | 0.3x | 0.3x | 0.3x | 0.3x | 0.2x | 1.8x | β | 1.0x | 0.9x |
| Interest coverage | 13.0x | 9.0x | 12.2x | 6.0x | 14.1x | 28.5x | 5.3x | β9.9x | 0.6x | 0.8x |
| Current ratio | 3.6x | 3.7x | 3.7x | 4.7x | 4.3x | 3.9x | 1.8x | 2.5x | 2.1x | 2.4x |
| Quick ratio | 3.0x | 3.1x | 3.3x | 3.9x | 3.5x | 3.0x | 1.3x | 1.8x | 1.5x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.1% | 6.0% | 2.7% | 4.2% | 5.5% | 3.5% | 3.7% | 3.4% | 0.9% | 0.9% |
| Stock comp / revenue | 5.7% | 8.5% | 10.7% | 9.5% | 8.9% | 6.9% | 5.2% | 4.6% | 7.5% | 5.5% |
| Payouts / FCF | 1.2% | 19.5% | 69.8% | 73.5% | 82.9% | 73.3% | 50.8% | β | 0.0% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 6.0 | 7.0 | 7.0 | 7.0 | 8.0 | 5.0 | 3.0 | 6.0 | 7.0 |
| Altman Z'' | 5.7 | 5.6 | 6.5 | 6.4 | 6.6 | 7.3 | 2.6 | β3.9 | 1.4 | 1.6 |
| Accruals ratio | β6.6% | β7.3% | β10.6% | β8.2% | β5.5% | β7.0% | β3.5% | β50.6% | β15.8% | β15.7% |
Source: SEC EDGAR XBRL filings (CIK 0000088941). Data updated October 17, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.